Sinotherapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	83.78	407.11	225.79	641.79	763.27	511.66
Short-Term Investments	-	-	-	107.21	44.09	-
Trading Asset Securities	730.25	339.34	507.74	-	-	-
Cash & Short-Term Investments	814.03	746.45	733.53	749	807.36	511.66
Cash Growth	6.33%	1.76%	-2.07%	-7.23%	57.79%	17.85%
Accounts Receivable	56.42	86.25	110.97	78.47	71.27	44.09
Other Receivables	2.81	3.24	0.3	0.57	-	-
Receivables	59.23	89.49	111.27	79.04	71.27	44.09
Inventory	93.34	72.55	102.42	84.61	29.38	40.43
Other Current Assets	26.35	26.38	29.1	39.36	45.7	22.66
Total Current Assets	992.96	934.87	976.32	952.01	953.71	618.83
Property, Plant & Equipment	355.54	363.88	344.34	271.41	255.92	115.09
Long-Term Investments	91.61	64.27	64.42	64.2	49.1	69.99
Goodwill	16.22	16.22	18.39	18.39	18.39	-
Other Intangible Assets	10.99	14.98	21.65	27.59	32.47	41.16
Long-Term Deferred Tax Assets	20.3	19.01	19.33	14.29	16.45	16.08
Long-Term Deferred Charges	0.22	0.46	0.92	1.21	1.99	3.15
Other Long-Term Assets	3.11	24.41	7.94	12.54	4.3	1.5
Total Assets	1,491	1,438	1,453	1,362	1,332	865.81

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	39.51	19.24	16.75	13.34	8.42	8.01
Accrued Expenses	8.84	12.47	26.49	14.69	11.58	14.19
Current Portion of Leases	-	0.02	0.01	0.06	0.32	0.78
Current Income Taxes Payable	0.74	1.07	6.97	1.28	0.45	7.85
Current Unearned Revenue	39.85	29.91	30.44	48.01	56.8	46.78
Other Current Liabilities	24.04	20.24	22.54	13.33	12.47	11.92
Total Current Liabilities	113.02	82.96	103.19	90.72	90.05	89.52
Long-Term Leases	-	-	-	0.02	1.2	3.66
Long-Term Unearned Revenue	52.96	58.43	74.72	58.09	61.12	64.62
Long-Term Deferred Tax Liabilities	2.14	2.25	2.39	2.53	2.68	2.82
Other Long-Term Liabilities	4.66	2.48	-	-	-	-
Total Liabilities	172.78	146.12	180.3	151.36	155.05	160.62

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	453.34	453.34	453.34	453.34	453.34	408
Additional Paid-In Capital	516.3	512.92	513.57	512.89	512.89	179.23
Retained Earnings	384.72	361.86	342.22	244.16	211.19	118.26
Treasury Stock	-36.13	-36.13	-36.13	-	-	-
Comprehensive Income & Other	-0.05	-0.02	-	-0.13	-0.15	-0.31
Shareholders' Equity	1,318	1,292	1,273	1,210	1,177	705.19
Total Liabilities & Equity	1,491	1,438	1,453	1,362	1,332	865.81

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.04	0.02	0.01	0.09	1.52	4.44
Net Cash (Debt)	813.99	746.43	733.53	748.92	805.84	507.22
Net Cash Growth	6.33%	1.76%	-2.05%	-7.06%	58.87%	16.82%
Net Cash Per Share	1.98	1.73	1.61	1.59	1.91	1.24
Filing Date Shares Outstanding	429.4	449	449	449.15	453.34	408
Total Common Shares Outstanding	429.4	449	449	453.34	453.34	408
Working Capital	879.94	851.91	873.13	861.29	863.66	529.31
Book Value Per Share	3.07	2.88	2.84	2.67	2.60	1.73
Tangible Book Value	1,291	1,261	1,233	1,164	1,126	664.02
Tangible Book Value Per Share	3.01	2.81	2.75	2.57	2.48	1.63
Buildings	-	251.86	216.23	211.68	54.29	52.41
Machinery	-	214.98	183.49	160.89	145.6	135.93
Construction In Progress	-	57.58	80.75	15.35	153.61	4.68